Your browser doesn't support javascript.
loading
Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathway.
Wei, Linhua; Chen, Weiwei; Huang, Linke; Wang, Hui; Su, Yuangang; Liang, Jiamin; Lian, Haoyu; Xu, Jiake; Zhao, Jinmin; Liu, Qian.
Afiliación
  • Wei L; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China; Department of Orthopaedics, Affiliated Infectious Diseases Hospital of Guangxi Medical University, The Fourth People's Hospital of Na
  • Chen W; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Pr
  • Huang L; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China; Department of Orthopaedics, The Second Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, Guangx
  • Wang H; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Su Y; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Pr
  • Liang J; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Pr
  • Lian H; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Pr
  • Xu J; School of Biomedical Sciences, University of Western Australia, Perth, WA, 6009, Australia.
  • Zhao J; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Pr
  • Liu Q; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China. Electronic address: liuqian@gxmu.edu.cn.
Pharmacol Res ; 184: 106400, 2022 10.
Article en En | MEDLINE | ID: mdl-35988868
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Osteólisis / Conservadores de la Densidad Ósea Límite: Animals Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Osteólisis / Conservadores de la Densidad Ósea Límite: Animals Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article